RecruitingNCT03731130
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
Sponsor
Ludwig-Maximilians - University of Munich
Enrollment
100 participants
Start Date
Oct 5, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional Outcome, oncological outcome and toxicity in patients treated with neoadjuvant short term radiation or long-term chemoradiation followed by surgery
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- histologically proven rectal Cancer without distant metastases
- indication for neoadjuvant Radiation or chemoradiation therapy according to multidiciplinary Evaluation
- age \>=18 years
- written informed consent
- ability to answer the standardized questionaires according to the treating physician
Exclusion Criteria4
- age \< 18 years
- prior systemic therapy with regard to rectal Cancer
- distant metastasis
- second malignancy
Interventions
OTHEREORTC QLQ C30
standardized questionaire
OTHEREORTC QLQ CR29
standardized questionaire
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03731130
Related Trials
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
NCT058069319 locations
Resilience and Equity in Aging, Cancer, and Health (REACH)
NCT046742671 location
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
NCT066374626 locations
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)
NCT0701157614 locations
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
NCT072097871 location